Walthausen & Co’s NuVasive, Inc. NUVA Stock Holding History

Walthausen & Co’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.11M	Sell	25,291 -14,755	-37%	-$715K	0.92%	65
2022 Q2	$1.97M	Sell	40,046 -2,140	-5%	-$115K	0.88%	33
2022 Q1	$2.39M	Sell	42,186 -1,210	-3%	-$64.3K	0.67%	77
2021 Q4	$2.28M	Buy	43,396 +1,841	+4%	+$100K	0.6%	101
2021 Q3	$2.49M	Sell	41,555 -11,435	-22%	-$705K	0.63%	87
2021 Q2	$3.59M	Buy	52,990 +770	+1%	+$52.6K	0.79%	40
2021 Q1	$3.42M	Buy	52,220 +14,590	+39%	+$875K	0.72%	54
2020 Q4	$2.12M	Buy	+37,630	New	+$1.85M	0.58%	83

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Walthausen & Co's NUVA Position: Q3 2022 in Review

Walthausen & Co reduced its NuVasive, Inc. (NUVA) stake by 37% in Q3 2022, selling an estimated $715K and leaving 25,291 shares worth $1.11M. The position accounts for 0.92% of the portfolio, ranked #65.

Walthausen & Co first reported a position in NUVA in Q4 2020 and has held it in 8 quarters since. The position peaked at $3.59M in Q2 2021. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

Walthausen & Co held 25,291 shares of NuVasive, Inc. worth $1.11M as of Q3 2022.
Walthausen & Co sold 14,755 NuVasive, Inc. shares in Q3 2022, an estimated $715K.
NuVasive, Inc. made up 0.92% of Walthausen & Co's portfolio in Q3 2022, its #65 holding.
Walthausen & Co first reported a position in NuVasive, Inc. in Q4 2020 and has held it in 8 quarters since.
Walthausen & Co's NuVasive, Inc. position peaked at $3.59M in Q2 2021.
232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on Walthausen & Co's 13F filing for Q3 2022, filed 14 Nov 2022.